Free Trial
→ Take a look at this picture ... (From Weiss Ratings) (Ad) Free ERNA Stock Alerts

Ernexa Therapeutics (ERNA) SEC Filings & 10K Form

Ernexa Therapeutics logo
$1.70 +0.05 (+3.19%)
Closing price 03:59 PM Eastern
Extended Trading
$1.68 -0.01 (-0.88%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Ernexa Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/07/2025
7:00 PM		Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2025
11:15 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form EFFECT
06/11/2025
7:34 PM		Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
7:39 PM		Cherington Charles (Filed by)
Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
Form SCHEDULE 13D/A
06/11/2025
3:30 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/11/2025
3:35 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/15/2025
8:13 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
05/15/2025
3:42 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
Konar Shameek (Filed by)
Form SCHEDULE 13G
05/14/2025
7:39 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
1:14 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
10:48 AM		Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Form 4/A
04/29/2025
11:15 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form EFFECT
04/16/2025
3:30 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/14/2025
4:05 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form ARS
04/04/2025
9:54 AM		Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
9:55 AM		Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Form SCHEDULE 13D/A
04/03/2025
4:17 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form PRE 14A
04/03/2025
7:55 AM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
6:30 AM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:15 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:20 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
4:55 PM		Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Form SCHEDULE 13D/A
02/14/2025
8:30 PM		Eterna Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Singer Nicholas Jason (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:36 PM		Eterna Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:54 PM		Eterna Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Luther Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Wexler William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:31 PM		Eterna Therapeutics Inc. (Subject)
Ernexa Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:00 PM		Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
4:01 PM		Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/17/2024
11:15 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form EFFECT
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
$100 Trillion “AI Metal” Found in American Ghost Town (Ad)

Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.

Click here to get the details on this virtual monopoly.
11/05/2024
11:42 AM		Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Ernexa Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form ARS
09/27/2024
3:47 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form PRE 14A
09/27/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Ernexa Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ERNA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Crypto bros: Meet your replacement
Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...
Brownstone Research | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Former CIA Officer Reveals How Gold Saved His Life
This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...
Advantage Gold | Sponsored
How high will gold surge?
Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...
Weiss Ratings | Sponsored